Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-28

Clinical Trial Update: The SHINE-MDT Randomized Controlled Trial [NA]

View source ↗

Summary

The SHINE-MDT randomized controlled trial has completed enrollment/status, focusing on head and neck cancer and radiotherapy-related side effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Carcinoma, Radiotherapy Side Effects | NA | Status: COMPLETED